Document Detail

Comparing asthma treatment in elderly versus younger patients.
MedLine Citation:
PMID:  21435854     Owner:  NLM     Status:  MEDLINE    
A randomised 6-month study compared two maintenance doses of budesonide/formoterol (Symbicort® Turbuhaler® (h) maintenance and reliever therapy (Symbicort SMART®), 160/4.5 μg 1 × 2 and 2 × 2, in 8053 asthmatics with symptoms despite treatment with inhaled corticosteroids ± inhaled long-acting β2-agonists. This analysis compared response to the two treatments in elderly patients, ≥ 65 years, with that in younger patients. Elderly patients with early- or late-onset asthma were also compared. Elderly patients had lower post-bronchodilator FEV1 percentage predicted normal at baseline than younger patients (85.6% vs. 91.0%, respectively). The elderly had more exacerbations and risk of first severe exacerbation was increased by 55.3% (hazard ratio 1.553; 95% confidence interval: 1.249-1.931, p < 0.0001). However, no differences in exacerbations were seen between 1 × 2 or 2 × 2 budesonide/formoterol maintenance and reliever therapy treatment in the elderly. Five-item Asthma Control Questionnaire (ACQ-5) scores improved equally in the two age groups. Changes in mean ACQ-5 scores between 1 × 2 and 2 × 2 were significant in both age groups but not clinically relevant (≥ 65 years, 0.12; p = 0.018; <65 years, 0.09; p < 0.0001). Elderly patients with early- and late-onset asthma responded equally well to treatment. Budesonide/formoterol maintenance and reliever therapy (1 × 2 or 2 × 2) is an effective, well-tolerated and practical treatment concept in elderly and younger asthmatic patients.
J Haughney; M Aubier; L Jørgensen; J Ostinelli; O Selroos; C P van Schayck; R Buhl
Related Documents :
9111464 - Unilateral neglect syndrome rehabilitation by trunk rotation and scanning training.
6376714 - Carotid endarterectomy in patients with transient cerebral ischaemia.
17388994 - One-year outcome after first-ever stroke according to stroke subtype, severity, risk fa...
20597864 - Predictors of good clinical outcome in acute stroke patients treated with intravenous t...
12121564 - Short-term methotrexate therapy in psoriasis: a study of 197 patients.
3769774 - Evaluation of a computerized reminder system in the enhancement of patient medication r...
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2011-03-23
Journal Detail:
Title:  Respiratory medicine     Volume:  105     ISSN:  1532-3064     ISO Abbreviation:  Respir Med     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-04-25     Completed Date:  2011-06-30     Revised Date:  2013-06-11    
Medline Journal Info:
Nlm Unique ID:  8908438     Medline TA:  Respir Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  838-45     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Ltd. All rights reserved.
Academic Primary Care, University of Aberdeen, Foresterhill Health Centre, Westburn Road, Aberdeen, Scotland AB25 2AY, UK.
Data Bank Information
Bank Name/Acc. No.:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Inhalation
Asthma / drug therapy*,  physiopathology,  psychology
Bronchodilator Agents / administration & dosage*
Budesonide / administration & dosage*
Disease Progression
Dose-Response Relationship, Drug
Drug Therapy, Combination / methods
Ethanolamines / administration & dosage*
Quality of Life / psychology
Treatment Outcome
Reg. No./Substance:
0/Bronchodilator Agents; 0/Ethanolamines; 51333-22-3/Budesonide; 5ZZ84GCW8B/formoterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Postnatal development in Andersen's leaf-nosed bat Hipposideros pomona: flight, wing shape, and wing...
Next Document:  The impact of COPD on ICU mortality in patients with ventilator-associated pneumonia.